Clinical Trial Update: Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety, tolerability, and effect on body weight of metreleptin administered with pramlintide in overweight and obese adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• MYALEPT (METRELEPTIN)
• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Overweight, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2013-11-14